{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:59:27Z","timestamp":1791327567602,"version":"4.3.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":3144,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1074\/jbc.m111.277178","type":"journal-article","created":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T20:50:09Z","timestamp":1320785409000},"page":"3617-3629","source":"Crossref","is-referenced-by-count":194,"title":["Functional Selective Oxytocin-derived Agonists Discriminate between Individual G Protein Family Subtypes"],"prefix":"10.1016","volume":"287","author":[{"given":"Marta","family":"Busnelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Sauli\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Gal\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bice","family":"Chini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M111.277178_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology","volume":"320","author":"Urban","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1074\/jbc.M111.277178_bib2","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1210\/me.2006-0220","article-title":"Oxytocin receptors differentially signal via Gq and Gi proteins in pregnant and nonpregnant rat uterine myocytes: implications for myometrial contractility","volume":"21","author":"Zhou","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1074\/jbc.M111.277178_bib3","first-page":"E870","article-title":"Coupling of oxytocin receptor to G proteins in rat myometrium during labor: Gi receptor interaction","volume":"272","author":"Strakova","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1074\/jbc.M111.277178_bib4","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1471-4159.2010.06861.x","article-title":"Dual modulation of inward rectifier potassium currents in olfactory neuronal cells by promiscuous G protein coupling of the oxytocin receptor","volume":"114","author":"Gravati","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1074\/jbc.M111.277178_bib5","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1038\/sj.onc.1206612","article-title":"Oxytocin receptor elicits different EGFR\/MAPK activation patterns depending on its localization in caveolin-1 enriched domains","volume":"22","author":"Rimoldi","year":"2003","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M111.277178_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1113\/eph8602179","article-title":"Hormones and calcium: mechanisms controlling uterine smooth muscle contractile activity: the Litchfield Lecture","volume":"86","author":"Sanborn","year":"2001","journal-title":"Exp. Physiol."},{"key":"10.1074\/jbc.M111.277178_bib7","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/sj.onc.1205219","article-title":"Localization of the human oxytocin receptor in caveolin-1 enriched domains turns the receptor-mediated inhibition of cell growth into a proliferative response","volume":"21","author":"Guzzi","year":"2002","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M111.277178_bib8","doi-asserted-by":"crossref","first-page":"16311","DOI":"10.1074\/jbc.M409945200","article-title":"The oxytocin receptor antagonist atosiban inhibits cell growth via a \u201cbiased agonist\u201d mechanism","volume":"280","author":"Reversi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.277178_bib9","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/1541-7786.MCR-09-0329","article-title":"Oxytocin induces the migration of prostate cancer cells: involvement of the Gi-coupled signaling pathway","volume":"8","author":"Zhong","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"10.1074\/jbc.M111.277178_bib10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/(SICI)1097-0215(19960611)66:6<817::AID-IJC18>3.0.CO;2-#","article-title":"Oxytocin and oxytocin analogue F314 inhibit cell proliferation and tumor growth of rat and mouse mammary carcinomas","volume":"66","author":"Cassoni","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1074\/jbc.M111.277178_bib11","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.neuron.2010.03.005","article-title":"The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior","volume":"65","author":"Insel","year":"2010","journal-title":"Neuron"},{"key":"10.1074\/jbc.M111.277178_bib12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/jama.2011.117","article-title":"Scientists probe oxytocin therapy for social deficits in autism, schizophrenia","volume":"305","author":"Kuehn","year":"2011","journal-title":"JAMA"},{"key":"10.1074\/jbc.M111.277178_bib13","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nsmb1134","article-title":"Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes","volume":"13","author":"Gal\u00e9s","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1074\/jbc.M111.277178_bib14","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1002\/j.1460-2075.1995.tb07211.x","article-title":"Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor","volume":"14","author":"Chini","year":"1995","journal-title":"EMBO J."},{"key":"10.1074\/jbc.M111.277178_bib15","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1681\/ASN.V1161033","article-title":"Nephrogenic diabetes insipidus: functional analysis of new AVPR2 mutations identified in Italian families","volume":"11","author":"Albertazzi","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1074\/jbc.M111.277178_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/me.2002-0222","article-title":"Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis","volume":"17","author":"Terrillon","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1074\/jbc.M111.277178_bib17","doi-asserted-by":"crossref","first-page":"13703","DOI":"10.1074\/jbc.M608846200","article-title":"Dopamine receptor-interacting protein 78 acts as a molecular chaperone for G\u03b3 subunits before assembly with G\u03b2","volume":"282","author":"Dupr\u00e9","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.277178_bib18","doi-asserted-by":"crossref","first-page":"11406","DOI":"10.1073\/pnas.1936664100","article-title":"\u03b2-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors","volume":"100","author":"Azzi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.277178_bib19","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/emboj\/cdg383","article-title":"Phosphorylation-independent desensitization of GABA(B) receptor by GRK4","volume":"22","author":"Perroy","year":"2003","journal-title":"EMBO J."},{"key":"10.1074\/jbc.M111.277178_bib20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0079-6123(08)00437-8","article-title":"Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents","volume":"170","author":"Manning","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1074\/jbc.M111.277178_bib21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/psc.667","article-title":"Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban","volume":"11","author":"Manning","year":"2005","journal-title":"J. Pept. Sci."},{"key":"10.1074\/jbc.M111.277178_bib22","doi-asserted-by":"crossref","first-page":"E532","DOI":"10.1152\/ajpendo.90590.2008","article-title":"Intracellular trafficking of the human oxytocin receptor: evidence of receptor recycling via a Rab4\/Rab5 \u201cshort cycle\u201d","volume":"296","author":"Conti","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1074\/jbc.M111.277178_bib23","first-page":"321","article-title":"Molecular basis for agonist selectivity in the vasopressin\/oxytocin receptor family","volume":"395","author":"Chini","year":"1995","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1074\/jbc.M111.277178_bib24","doi-asserted-by":"crossref","first-page":"25771","DOI":"10.1074\/jbc.270.43.25771","article-title":"The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions","volume":"270","author":"Mouillac","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.277178_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nmeth743","article-title":"Real-time monitoring of receptor and G-protein interactions in living cells","volume":"2","author":"Gal\u00e9s","year":"2005","journal-title":"Nat. Methods"},{"key":"10.1074\/jbc.M111.277178_bib26","doi-asserted-by":"crossref","first-page":"15078","DOI":"10.1074\/jbc.M707941200","article-title":"Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing \u03b4-opioid receptors and heterotrimeric G proteins","volume":"283","author":"Audet","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.277178_bib27","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.1158\/0008-5472.CAN-06-4623","article-title":"An improved bioluminescence resonance energy transfer strategy for imaging intracellular events in single cells and living subjects","volume":"67","author":"De","year":"2007","journal-title":"Cancer Res."},{"key":"10.1074\/jbc.M111.277178_bib28","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/protein\/gzl023","article-title":"Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output","volume":"19","author":"Loening","year":"2006","journal-title":"Protein Eng. Des. Sel"},{"key":"10.1074\/jbc.M111.277178_bib29","first-page":"cm10","article-title":"Seven-transmembrane receptor signaling through \u03b2-arrestin","author":"Shenoy","year":"2005","journal-title":"Sci. STKE 2005"},{"key":"10.1074\/jbc.M111.277178_bib30","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1681\/ASN.2008121289","article-title":"Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus","volume":"20","author":"Jean-Alphonse","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1074\/jbc.M111.277178_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/mol.106.028258","article-title":"An opioid agonist that does not induce \u03bc-opioid receptor\u2013arrestin interactions or receptor internalization","volume":"71","author":"Groer","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1074\/jbc.M111.277178_bib32","first-page":"3684","article-title":"Detection of \u03b22-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET)","volume":"97","author":"Angers","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.277178_bib33","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1210\/me.2003-0440","article-title":"Real-time detection of interactions between the human oxytocin receptor and G protein-coupled receptor kinase-2","volume":"18","author":"Hasbi","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1074\/jbc.M111.277178_bib34","first-page":"899","article-title":"Evidence of oxytocin\/oxytocin receptor interplay in human prostate gland and carcinomas","volume":"25","author":"Cassoni","year":"2004","journal-title":"Int. J. Oncol."},{"key":"10.1074\/jbc.M111.277178_bib35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1677\/joe.0.1360497","article-title":"Oxytocin-stimulated phosphoinositide hydrolysis in human myometrial cells: involvement of pertussis toxin-sensitive and -insensitive G-proteins","volume":"136","author":"Phaneuf","year":"1993","journal-title":"J. Endocrinol."},{"key":"10.1074\/jbc.M111.277178_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.febslet.2004.10.108","article-title":"A Gly\/Ala switch contributes to high affinity binding of benzoxazinone-based non-peptide oxytocin receptor antagonists","volume":"579","author":"Hawtin","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1074\/jbc.M111.277178_bib37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/978-1-4615-4871-3_48","article-title":"Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling","volume":"449","author":"Postina","year":"1998","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1074\/jbc.M111.277178_bib38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0014-5793(96)01135-0","article-title":"Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin","volume":"397","author":"Chini","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1074\/jbc.M111.277178_bib39","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1124\/mol.56.1.214","article-title":"Activation mechanism of human oxytocin receptor: a combined study of experimental and computer-simulated mutagenesis","volume":"56","author":"Fanelli","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1074\/jbc.M111.277178_bib40","doi-asserted-by":"crossref","first-page":"9990","DOI":"10.1021\/bi0509853","article-title":"The DRY motif as a molecular switch of the human oxytocin receptor","volume":"44","author":"Favre","year":"2005","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.M111.277178_bib41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrd3024","article-title":"Teaching old receptors new tricks: biasing seven-transmembrane receptors","volume":"9","author":"Rajagopal","year":"2010","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1074\/jbc.M111.277178_bib42","doi-asserted-by":"crossref","first-page":"19452","DOI":"10.1074\/jbc.M101450200","article-title":"Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-\u03b2-arrestin complexes after receptor endocytosis","volume":"276","author":"Oakley","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.277178_bib43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/me.2005-0031","article-title":"Internalization and desensitization of the oxytocin receptor is inhibited by dynamin and clathrin mutants in human embryonic kidney 293 cells","volume":"20","author":"Smith","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1074\/jbc.M111.277178_bib44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1124\/jpet.109.156398","article-title":"Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands","volume":"331","author":"Leduc","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1074\/jbc.M111.277178_bib45","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1096\/fj.10-154997","article-title":"Differential association modes of the thrombin receptor PAR1 with G\u03b1i1, G\u03b112, and \u03b2-arrestin 1","volume":"24","author":"Ayoub","year":"2010","journal-title":"FASEB J."},{"key":"10.1074\/jbc.M111.277178_bib46","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1124\/mol.106.030304","article-title":"Real-time analysis of agonist-induced activation of protease-activated receptor 1\/G\u03b1i1 protein complex measured by bioluminescence resonance energy transfer in living cells","volume":"71","author":"Ayoub","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1074\/jbc.M111.277178_bib47","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1124\/mol.106.032722","article-title":"Protean agonism at the dopamine D2 receptor: (S)-3-(3-hydroxyphenyl)-N-propylpiperidine is an agonist for activation of Go1 but an antagonist\/inverse agonist for Gi1, Gi2, and Gi3","volume":"71","author":"Lane","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1074\/jbc.M111.277178_bib48","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1124\/jpet.104.071415","article-title":"Coexpression of Y1, Y2, and Y4 receptors in smooth muscle coupled to distinct signaling pathways","volume":"311","author":"Misra","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1074\/jbc.M111.277178_bib49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0167-4889(91)90008-L","article-title":"Analysis by mRNA levels of the expression of six G protein \u03b1-subunit genes in mammalian cells and tissues","volume":"1094","author":"Garibay","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M111.277178_bib50","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/sj.bjc.6601189","article-title":"Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue","volume":"89","author":"Chini","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1074\/jbc.M111.277178_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2005.01.010","article-title":"Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin","volume":"510","author":"Gimpl","year":"2005","journal-title":"Eur. J. Pharmacol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820481748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820481748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M111.277178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T11:00:03Z","timestamp":1713092403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820481748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0021925820481748"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m111.277178","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}